1. Restricted transgene expression in the brain with cell-type specific neuronal promoters.
- Author
-
Delzor A, Dufour N, Petit F, Guillermier M, Houitte D, Auregan G, Brouillet E, Hantraye P, and Déglon N
- Subjects
- Animals, Brain pathology, Genes, Reporter, Genetic Vectors genetics, Genetic Vectors metabolism, Glutamate Decarboxylase genetics, Glutamate Decarboxylase metabolism, Hippocampus metabolism, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Lentivirus genetics, Male, Mice, Neurons metabolism, Neurons pathology, Phosphoglycerate Kinase genetics, Phosphoglycerate Kinase metabolism, Phosphopyruvate Hydratase genetics, Phosphopyruvate Hydratase metabolism, Protein Precursors genetics, Protein Precursors metabolism, Rats, Receptors, AMPA genetics, Receptors, AMPA metabolism, Receptors, Dopamine D1 genetics, Receptors, Dopamine D1 metabolism, Tachykinins genetics, Tachykinins metabolism, Transcription, Genetic, Transduction, Genetic, Brain metabolism, Promoter Regions, Genetic genetics
- Abstract
Tissue-targeted expression is of major interest for studying the contribution of cellular subpopulations to neurodegenerative diseases. However, in vivo methods to investigate this issue are limited. Here, we report an analysis of the cell specificity of expression of fluorescent reporter genes driven by six neuronal promoters, with the ubiquitous phosphoglycerate kinase 1 (PGK) promoter used as a reference. Quantitative analysis of AcGFPnuc expression in the striatum and hippocampus of rodents showed that all lentiviral vectors (LV) exhibited a neuronal tropism; however, there was substantial diversity of transcriptional activity and cell-type specificity of expression. The promoters with the highest activity were those of the 67 kDa glutamic acid decarboxylase (GAD67), homeobox Dlx5/6, glutamate receptor 1 (GluR1), and preprotachykinin 1 (Tac1) genes. Neuron-specific enolase (NSE) and dopaminergic receptor 1 (Drd1a) promoters showed weak activity, but the integration of an amplification system into the LV overcame this limitation. In the striatum, the expression profiles of Tac1 and Drd1a were not limited to the striatonigral pathway, whereas in the hippocampus, Drd1a and Dlx5/6 showed the expected restricted pattern of expression. Regulation of the Dlx5/6 promoter was observed in a disease condition, whereas Tac1 activity was unaffected. These vectors provide safe tools that are more selective than others available, for the administration of therapeutic molecules in the central nervous system (CNS). Nevertheless, additional characterization of regulatory elements in neuronal promoters is still required.
- Published
- 2012
- Full Text
- View/download PDF